Caplight Directory>Investors>415 Capital>415capital


415 Capital

415 Capital

Munich, Bavaria415capital.com

Overview

415 Capital is a specialist venture capital firm dedicated to investing in breakthrough and life-saving medical innovation. They invest in early- and development-stage MedTech companies in Europe, the United States and Israel. They primarily invest in innovative medical device technologies addressing cardiovascular and neurovascular diseases.

Year Founded

2018

AUM

$200M

Portfolio Companies

9

Investments

CompanyDateStageLead
Endovascular Engineering, Inc.Apr 2026Series CCo-investor
Supira MedicalMar 2025Series ECo-investor
Endovascular Engineering, Inc.Feb 2025Series BLead
CorflowSep 2024Series BCo-investor
R3 VascularMay 2024Series BCo-investor
View all investments

Key People

David P. Thompson

Co-Founder General Partner

Azin Parhizgar

Sr Venture Partner

Michael Braun

Senior Venture Partner

Rob Michiels

Senior Venture Partner

Linus Rieder

Principal

View all key people

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersMunich, Bavaria
Year Founded2018
AUM$200M

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.